تخطي إلى المحتوى الرئيسي

Peroxisomal acyl-CoA oxidase deficiency

Peroxisomal acyl-CoA oxidase deficiency is a disorder that causes deterioration of nervous system functions (neurodegeneration) beginning in infancy. Newborns with peroxisomal acyl-CoA oxidase deficiency have weak muscle tone (hypotonia) and seizures. They may have unusual facial features, including widely spaced eyes (hypertelorism), a low nasal bridge, and low-set ears. Extra fingers or toes (polydactyly) or an enlarged liver (hepatomegaly) also occur in some affected individuals.

الوصف

Peroxisomal acyl-CoA oxidase deficiency is a disorder that causes deterioration of nervous system functions (neurodegeneration) beginning in infancy. Newborns with peroxisomal acyl-CoA oxidase deficiency have weak muscle tone (hypotonia) and seizures. They may have unusual facial features, including widely spaced eyes (hypertelorism), a low nasal bridge, and low-set ears. Extra fingers or toes (polydactyly) or an enlarged liver (hepatomegaly) also occur in some affected individuals.

Most babies with peroxisomal acyl-CoA oxidase deficiency learn to walk and begin speaking, but they experience a gradual loss of these skills (developmental regression), usually beginning between the ages of 1 and 3. As the condition gets worse, affected children develop exaggerated reflexes (hyperreflexia), increased muscle tone (hypertonia), more severe and recurrent seizures (epilepsy), and loss of vision and hearing. Most children with peroxisomal acyl-CoA oxidase deficiency do not survive past early childhood.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.

Other names

Acyl-coenzyme A oxidase deficiency

Pseudo-NALD

Pseudoadrenoleukodystrophy

Pseudoneonatal adrenoleukodystrophy

Straight-chain acyl-CoA oxidase deficiency

Related patient information and medicines

اختبار بقعة الدم لحديثي الولادة

Patient information leaflet

اختبار بقعة الدم لحديثي الولادة

Mothers of all newborn babies are offered testing for certain rare but serious health conditions by testing blood taken from the baby's heel. ... Medium-chain acyl-Co-A dehydrogenase deficiency (MCADD)- this is a very rare, but potentially life-threatening, inherited disorder, where fat cannot be broken down by the body as well as usual. Babies.

سوء الامتصاص المعوي

Patient information leaflet

سوء الامتصاص المعوي

Gastrointestinal malabsorption syndrome means a failure to fully absorb digested الأطعمة from the gut (bowel) into your body. There are many different causes. Prolonged intestinal malabsorption may cause problems because of a lack of carbohydrates, proteins, fats, minerals and vitamins that are essential to keep you healthy. The treatment will.

ضخامة الكريات وفقر الدم الضخم الأرومات

Patient information leaflet

ضخامة الكريات وفقر الدم الضخم الأرومات

Macrocytosis refers to red blood cells which are larger than normal. It does not cause any symptoms in itself. Macrocytosis symptoms You may also find relevant information in our other separate leaflet called What is blood. What is blood. Macrocytosis can exist without anaemia. Macrocytosis itself does not cause any symptoms but can be a sign of.

فقر الدم

Patient information leaflet

فقر الدم

فقر الدم means that you have fewer red blood cells than normal or you have less haemoglobin than normal in each red blood cell. In either case, a reduced amount of oxygen is carried around in the bloodstream. Anaemia types and causes Iron-deficiency anaemia Lack of iron is the most common type of anaemia in the UK. This is called iron-deficiency.

تضيق الشريان الأبهر

Patient information leaflet

تضيق الشريان الأبهر

تضيق الشريان الأبهر هو a type of congenital heart disease where there is a narrowing in part of the aorta, the main artery that leaves the left side of the heart. Normal heart detail Cross-section diagram of a normal heart PatientPicksPlaceholder Heart - lung circulation heart - lung circulation What is coarctation of the aorta. In.

هل يمكنني تناول ألوبورينول و ميرتازابين معًا؟

Patient information leaflet

هل يمكنني تناول ألوبورينول و ميرتازابين معًا؟

It is generally considered safe to take these two medications together. Why this happens Allopurinol and mirtazapine are processed by different pathways in the body. Allopurinol works by blocking an enzyme called xanthine oxidase to lower uric acid levels, while mirtazapine affects chemical messengers in the brain. They do not interfere with each.

قراءة إضافية ومراجع

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.
  • 18 Aug 2020 | أحدث إصدار
  • 1 Apr 2014 | نُشر في الأصل

انضم إلى المحادثة

شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

تنويه: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

صيدلية إلكترونية وعلاجات وخدمات صحية

وصول بسيط إلى العلاجات والخدمات الصحية الموثوقة عبر الإنترنت.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.